Heng Fai Ambrose Chan - Mar 31, 2025 Form SCHEDULE 13D Schedule Report for IMPACT BIOMEDICAL INC.

Filing Manager
Chan Heng Fai Ambrose
Reporting Manager
Heng Fai Ambrose Chan
Security
IMPACT BIOMEDICAL INC. Common Stock
Shares outstanding
12.1M shares
Disclosed Ownership
2.04M shares
Ownership
16.9%
Form type
SCHEDULE 13D
Date filed
4/2/2025, 09:55 PM
Date of event
Mar 31, 2025
Next filing
Apr 4, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Heng Fai Ambrose Chan 16.9% 2.04M 0 2.04M /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, an Individual 0001261725
Alset Inc. 16.9% 2.04M 0 2.04M /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Chief Executive Officer, Alset Inc. 0001750106
Alset International Limited 10.8% 1.31M 0 1.31M /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Chief Executive Officer, Alset International Limited 0001660984
Global Biomedical Pte. Ltd. 3.8% 453K 0 453K /s/ Heng Fai Ambrose Chan Heng Fai Ambrose Chan, Director, Global Biomedical Pte. Ltd. 0001823066